Publications

Feb 27, 2025

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity.

Ana-Sosa-Batiz F, Verma SK, Shafee N, Miller R, Conner C, Hastie KM, Timis J, Maule E, Nguyen MN, Tran L, Varghese K, Madany H, Street AE, Zandonatti M, Moi ML, Jarnagin K, Webb DR, Saphire EO, Kim K, Shresta S.
Mar 25, 2025

Distinct features of a peripheral T helper subset that drives the B cell response in dengue virus infection

Ansari A, Sachan S, Ahuja J, Venkadesan S, Nikam B, Kumar V, Jain S, Singh BP, Coshic P, Sikka K, Wig N, Sette A, Weiskopf D, Mohanty D, Soneja M, Gupta N
Feb 1, 2025

Innateness transcriptome gradients characterize mouse t lymphocyte populations

Ascui G, Cedillo-Castelan V, Mendis A, Phung E, Liu HY, Verstichel G, Chandra S, Murray MP, Luna C, Cheroutre H, Kronenberg M
Jul 1, 2025

Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era

Atkins KM, Wang M, Silos KD, Joung SY, Singh A, Peony O, Gasho JO, Lee Y, Gastelum K, Filart BA, Kwan AC, Mendez M, Liu Y, Belen P, Prostko JC, Frias EC, Ebinger JE, Sharma S, Sobhani K, Cheng S
Jul 1, 2025

Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19

Barrera A, Martínez-Valdebenito C, Nervi B, Gaete-Argel A, Gálvez NMS, Osses C, Vizcaya C, Ceballos ME, Pereira J, Chang M, Rojas L, Mondaca S, Henríquez C, Kalergis AM, Sette A, Grifoni A, Soto-Rifo R, Valiente-Echeverría F, Ferres M, Balcells ME, Corre NL
Mar 31, 2025

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis

Barreto AS, de Franca MNF, Dos Reis TLDS, Silva JABM, Dos Santos PL, de Oliveira FA, da Silva AM, Magalhaes LS, Secco DA, Andrade MAF, Porto LC, Rosa DS, Cavalcante RCM, Corrêa CB, Sidney J, Sette A, de Almeida RP, Palatnik-de-Sousa CB
Jul 7, 2025

Soffritto: A deep learning model for predicting high-resolution replication timing

Bolzan D, Ay F
Mar 19, 2025

Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults

Capão A, Araújo MF, Tort LFL, Toledo TS, Oliveira ACA, Caetano BC, Resende PC, Martins-Filho OA, Ribeiro-Alves M, Grifoni A, Weiskopf D, Sette A, Siqueira MM, Côrtes FH, Garcia CC
Mar 4, 2025

Comparative performance analysis of neoepitope prediction algorithms in head and neck cancer

Chihab LY, Burel JG, Miller AM, Westernberg L, Brown B, Greenbaum J, Korrer MJ, Schoenberger SP, Joyce S, Kim YJ, Koşaloğlu-Yalçin Z, Peters B
Apr 3, 2025

Glycolysis model shows that allostery maintains high ATP and limits accumulation of intermediates

Choe M, Einav T, Phillips R, Titov DV
Jun 13, 2025

AbEpiTope-1.0: Improved antibody target prediction by use of AlphaFold and inverse folding

Clifford JN, Richardson E, Peters B, Nielsen M
Mar 28, 2025

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.

Cooper CL, Morrow G, Yuan M, Postler TS, Neal ML, Cross RW, Woolsey C, Agans KN, Borisevich V, McNamara RP, Atyeo C, Roy V, Germosen D, Hou F, Li SL, Reiserova L, Choi Y, Wilson A, Wagner D, Wallace-Selman O, Carpov A, Geng F, Frederick DJ, DeStefano J, Ercolini AM, Enriquez AS, Hastie KM, Ramos da Silva S, Sayeed E, Coleman JW, Kilianski A, Alter G, Saphire EO, Aitchison JD, Geisbert TW, Gupta SB, Feinberg MB, Parks CL.